SCHEMBL3263496

SCHEMBL3263496

C[Si](C)(C)C1CSCCS1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15709335 0.76
SCHEMBL10365591 0.63
SCHEMBL8335212 0.63
SCHEMBL851701 0.63
SCHEMBL14010698 0.61
SCHEMBL12217185 0.58
SCHEMBL3688203 0.58
SCHEMBL7222785 0.58
SCHEMBL5255304 0.57
SCHEMBL433119 0.57

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2719010-A2 MATERIALS FOR BATTERY ELECTROLYTES AND METHODS FOR USE Asahi Kasei Kabushiki Kaisha (JP) 2014-04-16 EP disclosed
WO-2014036024-A1 MATERIALS FOR BATTERY ELECTROLYTES AND METHODS FOR USE ASAHI KASEI KABUSHIKI KAISHA (JP) 2014-03-06 WO disclosed
WO-2014036026-A1 MATERIALS FOR BATTERY ELECTROLYTES AND METHODS FOR USE ASAHI KASEI KABUSHIKI KAISHA (JP) 2014-03-06 WO disclosed
WO-2012170688-A2 MATERIALS FOR BATTERY ELECTROLYTES AND METHODS FOR USE WILDCAT DISCOVERY TECHNOLOGIES, INC. (US) 2012-12-13 WO disclosed
US-8324203-B2 Azadecalin glucocorticoid receptor modulators CORCEPT THERAPEUTICS, INC. (US) 2012-12-04 US disclosed
US-20100120759-A1 AZADECALIN GLUCOCORTICOID RECEPTOR MODULATORS CORCEPT THERAPEUTICS, INC. (US) 2010-05-13 US disclosed
US-7678813-B2 Azadecalin Glucocorticoid receptor modulators CORCEPT THERAPEUTICS, INC. (US) 2010-03-16 US disclosed
EP-1761497-B1 AZADECALIN GLUCOCORTICOID RECEPTOR MODULATORS CORCEPT THERAPEUTICS INC (US) 2008-09-03 EP disclosed
CN-101119970-A Aza-decalin glucocorticoid receptor modulators CORCEPT THERAPEUTICS INC (US) 2008-02-06 CN disclosed
US-20070203179-A1 Azadecalin Glucocorticoid Receptor Modulators CORCEPT THERAPEUTICS, INC. (US) 2007-08-30 US disclosed
EP-0804427-A1 LTA4 HYDROLASE INHIBITORS G.D. SEARLE & CO. (US) 1997-11-05 EP disclosed
EP-0786992-A2 LTA 4? HYDROLASE INHIBITOR PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE G.D. SEARLE & CO. (US) 1997-08-06 EP disclosed
US-5585492-A USEFUL IN THE TREATMENT OF INFLAMMATORY DISEASES WHICH ARE MEDIATED BY LTB4 PRODUCTION, SUCH AS PSORIASIS, ULCERATIVE COLITIS, IRRITABLE BOWEL DISEASE AND ASTHMA G. D. SEARLE & CO. (US) 1996-12-17 US disclosed
WO-1996010999-A2 LTA4 HYDROLASE INHIBITOR PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE G.D. SEARLE & CO. (US) 1996-04-18 WO disclosed
WO-1996011192-A1 LTA4 HYDROLASE INHIBITORS G.D. SEARLE & CO. (US) 1996-04-18 WO disclosed
EP-0128654-B1 GEM-DIAMINOALKANE DERIVED SWEETENERS CUMBERLAND PACKING CORPORATION (US) 1989-10-18 EP disclosed
EP-0242896-A2 Novel intermediates useful in the production of gem-diaminoalkane derived sweeteners CUMBERLAND PACKING CORPORATION (US) 1987-10-28 EP disclosed
US-4571345-A 1,1-Diaminoalkane derived sweeteners CUMBERLAND PACKING CORP. (US) 1986-02-18 US disclosed
EP-0128654-A2 Gem-diaminoalkane derived sweeteners CUMBERLAND PACKING CORPORATION (US) 1984-12-19 EP disclosed
US-4224330-A Esters and thiolesters of benzothienyl acids ZOECON CORPORATION (US) 1980-09-23 US disclosed